Sign inJoin waitlistJoin the waitlist

David Goddard

Medical Director, NYU Langone Ambulatory Care Brooklyn Heights and NYU Langone Ambulatory Care Cobble Hill · NYU Grossman School of Medicine

Credentials: · · ·

History

NYU Langone Ambulatory Care Brooklyn Heights and NYU Langone Ambulatory Care Cobble Hill · NYU Grossman School of Medicine
Present
NYU Grossman School of Medicine
Present

Rheumatology
1977–1979
Internal Medicine
1974–1977
University of London
1970–1974

Research

Antiperinuclear factor and keratin antibodies in rheumatoid arthritis
Annals of the Rheumatic Diseases · 1981 · 83 citations
The myocardium in ankylosing spondylitis. A clinical, echocardiographic, and histopathological study
The Lancet · 1987 · 72 citations
Regulation of synovial cell growth. Coexpression of transforming growth factor beta and basic fibroblast growth factor by cultured synovial cells
Arthritis & Rheumatism · 1992 · First of 7 authors · 51 citations

AK
Alan Kivitz
1 paper
Alfred Kim
1 paper
Amit Saxena
1 paper
Eric Irwin
1 paper
FK
Fotios Koumpouras
1 paper
JF
Jeffrey Freedman
1 paper
Joshua Winder
1 paper
Kenneth Kalunian
1 paper
Maria Dall'Era
1 paper
MP
Megha Patel-Banker
1 paper
MK
Michael Kleerekoper
1 paper
PP
Paul Pickrell
1 paper

Clinical trials

EncompaSSc: Evaluation of MTX-474 in Participants With Diffuse Cutaneous Systemic Sclerosis (dcSSc)
Site PI · Recruiting · Phase 2
Mediar Therapeutics
2026–2028
A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines
Site PI · Recruiting · Phase 3
Takeda
2025–2028
A Study to Investigate the Long-term Safety and Efficacy of Belimumab in Adults With Interstitial Lung Disease (ILD) Associated With Systemic Sclerosis (SSc) and Other Connective Tissue Diseases (CTD) (BLISSconneCTD-OLE)
Site PI · Recruiting · Phase 3
GlaxoSmithKline
2024–2030
A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
Site PI · Recruiting · Phase 2, Phase 3
GlaxoSmithKline
2023–2029